Zetomipzomib ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
95自己免疫性肝炎1

95. 自己免疫性肝炎


臨床試験数 : 52 薬物数 : 68 - (DrugBank : 27) / 標的遺伝子数 : 18 - 標的パスウェイ数 : 111
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05569759
(ClinicalTrials.gov)
January 202329/9/2022A Study of Zetomipzomib (KZR-616) in Patients With Autoimmune Hepatitis (PORTOLA)A Randomized, Double-blind, Placebo-controlled, Phase 2a Study to Evaluate the Safety and Efficacy of Zetomipzomib (KZR-616) in Patients With Autoimmune HepatitisAutoimmune HepatitisDrug: zetomipzomib;Drug: placeboKezar Life Sciences, Inc.NULLRecruiting18 YearsN/AAll24Phase 2United States